CN102727698A - Wound surface nursing powder for treating bedsore - Google Patents

Wound surface nursing powder for treating bedsore Download PDF

Info

Publication number
CN102727698A
CN102727698A CN2012102421453A CN201210242145A CN102727698A CN 102727698 A CN102727698 A CN 102727698A CN 2012102421453 A CN2012102421453 A CN 2012102421453A CN 201210242145 A CN201210242145 A CN 201210242145A CN 102727698 A CN102727698 A CN 102727698A
Authority
CN
China
Prior art keywords
parts
wound surface
powder
bedsore
surface nursing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012102421453A
Other languages
Chinese (zh)
Other versions
CN102727698B (en
Inventor
尹德芬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhong Pharmaceutical Group Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210242145.3A priority Critical patent/CN102727698B/en
Publication of CN102727698A publication Critical patent/CN102727698A/en
Application granted granted Critical
Publication of CN102727698B publication Critical patent/CN102727698B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a wound surface nursing powder for treating bedsore, which aims at resolving a nursing problem of the bedsore. The wound surface nursing powder is characterized by being obtained by processing various traditional Chinese medicines, the raw material ingredients and weight proportions are as follows: 6-10 parts of dragon blood, 8-15 parts of elephant hide, 8-15 parts of frankincense, 6-10 parts of myrrh, 6-10 parts of lycopodium, 8-15 parts of beach morningglory herb, 6-10 parts of acacia catechu, 30-45 parts of radix angelicae and 30-40 parts of rhizoma atractylodis. Clinical experiments prove that the wound surface nursing powder has good curative effect on treating the bedsore with high safety and is worthy of clinical application and promotion.

Description

A kind of wound surface nursing powder of treating decubital ulcer
Technical field
The present invention relates to the nursing care of decubitus ulcer field, be specifically related to a kind of wound surface nursing powder of treating decubital ulcer.
Background technology
Decubital ulcer is owing to patient's long-term bed and nurses the improper body surface knuckle position pressurized, local Hypoxia and ischemia, blood vessel embolism, tissue necrosis corruption of causing and the downright bad ulcer zone that produces such as take off.Primary disease is more common in the patient of long-term bed such as stupor, hemiplegia, paralysis, also is found in after dressing compressing tension, the limbs stump of wearing artificial limb, the various operation patients such as position limitation of activity.Up to the present, the care method to decubital ulcer mainly is: wound surface is shallow, little, and pus oozes out few person, uses earlier the povidone iodine routine disinfection, and the back is dipped in normal saline with cotton swab and added gentamycin 80,000 U scouring repeatedly from inside to outside, fully exposes 1 time/d; Wound surface is dark, big, and pus oozes out more person, slough blackout and frowziness person; Thoroughly clean with 3% hydrogen peroxide liquid earlier, prune slough, until exposing fresh granulation tissue; Add gentamycin 80,000 U flushing wound surface with physiological saline solution then, cover 2 times/d with aseptic dressing.The weak point of this method is: be main with partial sterilization 1., when the middle and late stage granulation began to form, povidone iodine etc. had produced stimulation to granulation, caused the granulation dysplasia easily, and new meat is not given birth to; 2. flushing adds the therapeutic scheme that dressing covers, and transudate is easy to and the dressing adhesion, produces new wound when causing change dressings next time.
Summary of the invention
Technical assignment of the present invention is the deficiency to above prior art, and the wound surface nursing powder of the sure treatment decubital ulcer of a kind of curative effect is provided.
The technical scheme that the present invention solves its technical problem is: a kind of wound surface nursing powder of treating decubital ulcer, it is characterized in that processing by plurality of Chinese, and its composition of raw materials and weight proportion are: 6 ~ 10 parts of Sanguis Draxonis; 8 ~ 15 parts of Corium elephatiss, 8 ~ 15 parts of Olibanums, 6 ~ 10 parts of Myrrhas; 6 ~ 10 parts of Spora Lycopodiis, 8 ~ 15 parts of Herba Ipomoeae Pes-Capraes, 6 ~ 10 parts in catechu; 30 ~ 45 parts of the Radixs Angelicae Dahuricae, 30 ~ 40 parts of Rhizoma Atractylodis.
Its optimum weight proportioning is: 8 parts of Sanguis Draxonis, 10 parts of Corium elephatiss, 10 parts of Olibanums, 8 parts of Myrrhas, 8 parts of Spora Lycopodiis, 10 parts of Herba Ipomoeae Pes-Capraes, 8 parts in catechu, 40 parts of the Radixs Angelicae Dahuricae, 35 parts of Rhizoma Atractylodis.
Wherein said: Sanguis Draxonis, the resin that oozes out for babassu Sanguis Draxonis Daemonorops draco Blume. fruit is through being processed into.Nature and flavor are sweet, salty, and are flat.GUIXIN, Liver Channel.But the merit removing blood stasis and relieving pain, hemostasia and promoting granulation.
Corium elephatis is the skin of Elephantidae animal elephant Elephas maximus L..Nature and flavor are sweet, salty, temperature.But the merit granulation promoting is held back skin ulcer.
Olibanum, the oleo-gum-resin of oozing out for trunk skin zone wounds such as Burseraceae Boswellia carterii platymiscium Boswellia carterii Boswellia carterii Birdw., medicine glue XIANGSHU B. bhawdajiana Birdw. and wild Boswellia carterii B. neglecta M. Moore.Nature and flavor are hot, bitter, temperature.GUIXIN, liver, spleen channel.But the merit regulating qi and activating blood, analgesic therapy chases after poison.
Myrrha is for Burseraceae bdellium plant myrrh Commiphora myrrha Engl. and belong to the oleo-gum-resin that the trunk skin zone of his kind of plant oozes out together.Nature and flavor are bitter, and are flat.Return Liver Channel.The merit blood blood stasis removing that can loose, subduing swelling and relieving pain.
Spora Lycopodii is the spore of lycopsid Lycopodium clavatum copodium japonicum Thunb., Herba Lycopodii Obscuri Lycopodium clavatum Lycopodium centro-chinense Ching, Spora Lycopodii Palhinhaea cernua (L.) Franco et Vasc. and single fringe Lycopodium clavatum Lycopodium cernuum L..Nature and flavor are bitter; Temperature.Return liver; Spleen channel.But merit removing dampness; Hold back skin ulcer; Cough-relieving.
Herba Ipomoeae Pes-Capraes, the herb of Convolvulaceae morning glory two leaf Radix Ipomoeae Ipomoea pescarpae (L.) Sweet.Nature and flavor are hot, little hardship, and are wet.But the merit expelling wind and removing dampness, the detumescence of drawing out pus by applying a plaster to the affected part.
Catechu is the peeling branch of pulse family albizzia plant catechu tree Acacia catechu (L. f.) Willd., dried dry soft extracts.Nature and flavor are bitter, puckery, are slightly cold.Return lung meridian.But merit removing dampness promoting tissue regeneration and ulcer healing.
The Radix Angelicae Dahuricae is the dry root of plant Radix Angelicae Dahuricae Angelica dahurica (Fisch.ex Hoffm.) Benth. et Hook.f. of umbellate form section or Radix angelicae dahuricae Angelica dahurica (Fisch.ex Hoffm.) Benth.et Hook.f. var.formosana (Boiss.) Shan et Yuan.Nature and flavor are hot, temperature.Return stomach, large intestine, lung meridian.Can loose wind dehumidifying of merit, understand things pain-stopping, detumescence and apocenosis.
Rhizoma Atractylodis are the dry rhizome of feverfew Atractylodes lancea (Thunb.) DC. Atractylodes lancea (Thunb.) DC. or Atractylis chinensis Atractylodes chinensis (DC.) Koidz..Nature and flavor are hot, bitter, temperature.Return spleen, stomach, Liver Channel.Merit can be drying damp and strengthening spleen, and expelling wind and cold makes eye bright.
Composition principle: how the traditional Chinese medical science thinks decubital ulcer because of deficient qi and blood, and qi depression to blood stasis causes that prolonged illness is liied in bed in vain, pressurized position stagnation of QI-blood, and blood vessels are obstructed, and meridians intercept, and deficiency of both QI and blood is invaded in the malicious heresy, and the mistake of muscle muscles and bones is supported the corruption of then bursting and is become skin ulcer, and touching difficulty is more.Treatment at present is many with cold and cool medicine removing the necrotic tissue and promoting granulation, but in the process of treating patients with decubitus, the wound surface granulation is well grown, and is the key of decubital ulcer healing.The inventor promotes local vascular newborn in clinical empirical summary discovery for many years, corrects the local organization ischemic state, improves blood circulation, for the granulation tissue growth provides nutrition, is to be key.Simultaneously, should note effectively reducing oozing out, prevent loss of proteins, can help the improvement of local microenvironment like this, promote healing.So we get Sanguis Draxonis hemostasis by removing blood stasis granulation promoting, Olibanum regulating qi and activating blood, the diffusing blood blood stasis removing detumescence of Myrrha; Herba Ipomoeae Pes-Capraes, Rhizoma Atractylodis expelling wind and removing dampness; Corium elephatis, Spora Lycopodii, catechu removing dampness expelling pus and promoting granulation; The diffusing wind dehumidifying of the Radix Angelicae Dahuricae, detumescence and apocenosis.More than all medicines share, play the effect of invigorate blood circulation dehumidifying, expelling pus and promoting granulation altogether, promoted local blood circulation and angiogenesis, minimizing is oozed out, and effectively prevents loss of proteins, thus the alleviation decubitus and has been quickened the healing of decubital ulcer.
The specific embodiment
Below in conjunction with practical situation, specific embodiments of the invention elaborates.
Embodiment 1, the crude drug weight proportion: Sanguis Draxonis 6g, Corium elephatis 8g, Olibanum 8g, Myrrha 6g, Spora Lycopodii 6g, Herba Ipomoeae Pes-Capraes 8g, catechu 6g, Radix Angelicae Dahuricae 30g, Rhizoma Atractylodis 30g.
Embodiment 2, the crude drug weight proportion: Sanguis Draxonis 10g, Corium elephatis 15g, Olibanum 15g, Myrrha 10g, Spora Lycopodii 10g, Herba Ipomoeae Pes-Capraes 15g, catechu 10g, Radix Angelicae Dahuricae 45g, Rhizoma Atractylodis 40g.
Embodiment 3, the crude drug weight proportion: Sanguis Draxonis 8g, Corium elephatis 10g, Olibanum 10g, Myrrha 8g, Spora Lycopodii 8g, Herba Ipomoeae Pes-Capraes 10g, catechu 8g, Radix Angelicae Dahuricae 40g, Rhizoma Atractylodis 35g.
During use,, grind to the powder the autoclave sterilization external application altogether with Chinese medicine Sanguis Draxonis of the present invention, Corium elephatis, Olibanum, Myrrha, Spora Lycopodii, Herba Ipomoeae Pes-Capraes, catechu, Rhizoma Atractylodis and the Radix Angelicae Dahuricae.
Effective combination of above-mentioned wound surface nursing powder is coordinated mutually, can effectively reach the purpose of treatment decubital ulcer, and side effect is less.The above results is that clinical data proves that fully interrelated data is following, wherein studies wound surface nursing powder and is used for the crude drug weight proportion among the embodiment 3.
1 object and method.
1.1 object: the 71 examples decubital ulcer patients that are in hospital, male's 42 examples wherein, women's 29 examples; Age reckling 28 years old, the maximum 82 years old; The shortest 1 week of the course of disease, the longest 40 days; Minimum 2cm * the 2cm of area, maximum 10cm * 10cm.
1.2 method.
1.2.1 divide into groups: divide two groups at random, 41 examples are organized in treatment, matched group 30 examples, clinical data there was no significant difference between two groups (P>0.05).
1.2.2 Therapeutic Method: matched group: wound surface is shallow, little, and pus oozes out few person, uses earlier the povidone iodine routine disinfection, and the back is dipped in normal saline with cotton swab and added gentamycin 80,000 U scouring repeatedly from inside to outside, fully exposes 1 time/d; Wound surface is dark, big, and pus oozes out more person, slough blackout and frowziness person; Thoroughly clean with 3% hydrogen peroxide liquid earlier, prune slough, until exposing fresh granulation tissue; Add gentamycin 80,000 U flushing wound surface with physiological saline solution then, cover 2 times/d with aseptic dressing.The incrustation of skin ulcer face can 1 time/d after fresh granulation grows.Treatment group data scheme is to add the embodiment of the invention 3 gained Chinese medicines on the matched group basis again to grind to the powder altogether, the autoclave sterilization external application, and every day 1 time, 7 days is 1 course of treatment, continuous 4 courses of treatment.
1.2.3 observation index: observe and write down whether two groups of new meat of patient's wound surface grow, newly whether meat tissue covers with, whether wound surface forms a scab, and whether purulent secretion reduces, and whether swollen all around gesture fades.Observe local skin whether anaphylaxis is arranged.
1.2.4 Clinical criteria: Refer to the State Drug Administration in 1994 issued a "TCM Syndrome Diagnostic efficacy of the standard" recovery: medication 2-3 weeks, new flesh to grow, new flesh tissue covered the wound scab healed; ? Effective: purulent secretions decrease, surrounded by swelling potential fading; invalid: symptoms, signs changed little.
1.2.5 statistical analysis: carry out statistical analysis with SPSS 13.0, < 0.05 expression has the significance meaning to P.
2 results.
2.1 the curative effect of two groups of cases relatively: see the following form, cure rate and total effective rate treatment group obviously are superior to matched group (P < 0.05).
Figure 399513DEST_PATH_IMAGE001
2.2 untoward reaction situation: two groups are not all had the obvious adverse reaction case.
3. conclusion.
This result of study shows that the present invention treats the decubital ulcer determined curative effect, is worthy of promotion and application.

Claims (2)

1. a wound surface nursing powder of treating decubital ulcer is characterized in that being processed by plurality of Chinese, and its composition of raw materials and weight proportion are: 6 ~ 10 parts of Sanguis Draxonis; 8 ~ 15 parts of Corium elephatiss, 8 ~ 15 parts of Olibanums, 6 ~ 10 parts of Myrrhas; 6 ~ 10 parts of Spora Lycopodiis, 8 ~ 15 parts of Herba Ipomoeae Pes-Capraes, 6 ~ 10 parts in catechu; 30 ~ 45 parts of the Radixs Angelicae Dahuricae, 30 ~ 40 parts of Rhizoma Atractylodis.
2. a kind of wound surface nursing powder of treating decubital ulcer according to claim 1 is characterized in that its weight proportion is: 8 parts of Sanguis Draxonis, 10 parts of Corium elephatiss, 10 parts of Olibanums, 8 parts of Myrrhas, 8 parts of Spora Lycopodiis, 10 parts of Herba Ipomoeae Pes-Capraes, 8 parts in catechu, 40 parts of the Radixs Angelicae Dahuricae, 35 parts of Rhizoma Atractylodis.
CN201210242145.3A 2012-07-13 2012-07-13 Wound surface nursing powder for treating bedsore Active CN102727698B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210242145.3A CN102727698B (en) 2012-07-13 2012-07-13 Wound surface nursing powder for treating bedsore

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210242145.3A CN102727698B (en) 2012-07-13 2012-07-13 Wound surface nursing powder for treating bedsore

Publications (2)

Publication Number Publication Date
CN102727698A true CN102727698A (en) 2012-10-17
CN102727698B CN102727698B (en) 2014-03-12

Family

ID=46984462

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210242145.3A Active CN102727698B (en) 2012-07-13 2012-07-13 Wound surface nursing powder for treating bedsore

Country Status (1)

Country Link
CN (1) CN102727698B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103566088A (en) * 2013-10-31 2014-02-12 王凤华 Method for preparing preparation for treating bedsore in clinical nursing
CN104352568A (en) * 2014-12-11 2015-02-18 谭清平 Traditional Chinese medicine for treating bedsore and preparation method thereof
CN109009789A (en) * 2018-06-01 2018-12-18 南京梵康医疗科技有限公司 A kind of Medical nursing pad and its processing technology of pre- counteracting bedsores

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
于淑花: "《生肌愈创膏治疗褥疮临床观察》", 《中国中医急症》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103566088A (en) * 2013-10-31 2014-02-12 王凤华 Method for preparing preparation for treating bedsore in clinical nursing
CN103566088B (en) * 2013-10-31 2016-01-06 刘增慧 A kind of clinical care is used for the treatment of the preparation method of the medicament of decubital ulcer
CN104352568A (en) * 2014-12-11 2015-02-18 谭清平 Traditional Chinese medicine for treating bedsore and preparation method thereof
CN109009789A (en) * 2018-06-01 2018-12-18 南京梵康医疗科技有限公司 A kind of Medical nursing pad and its processing technology of pre- counteracting bedsores

Also Published As

Publication number Publication date
CN102727698B (en) 2014-03-12

Similar Documents

Publication Publication Date Title
CN101703603B (en) External-use ointment for treating empyrosis and preparation method thereof
CN102125634A (en) Chinese medicinal composition for treating bedsore
CN103230493B (en) Traditional Chinese medicine composition for treating unhealed wound
CN108186711A (en) Promote the pharmaceutical composition of wound healing
CN102068577A (en) Traditional Chinese medicine (TCM) composition and application thereof
CN102357203B (en) Cortex ulmis burn ointment for curing burns
CN103893557A (en) Traditional Chinese medicine preparation for treating bedsore
CN101011487A (en) Externally used Chinese patent drug for treating burn and scald and its preparation
CN102727698B (en) Wound surface nursing powder for treating bedsore
CN102861217A (en) External emplastrum for treating malignant boil, sores and carbuncles
CN112618646A (en) Traditional Chinese medicine composition and traditional Chinese medicine oil for treating burns and preparation method thereof
CN103566026B (en) A kind of burn medicine and preparation method and application
CN114886967B (en) Externally-applied traditional Chinese medicine composition for promoting tissue regeneration and preparation method thereof
CN105456326A (en) Traditional Chinese medicine for treating scalds as well as preparation method and application of traditional Chinese medicine
CN105250712B (en) A kind of Chinese medicine composition for treating bedsore
CN102698086A (en) Chinese medicinal emulsion for treating bedsore accumulated toxin decay
CN105770347A (en) Pure traditional Chinese medicinal oil for burns, scalds, wounds and ulcers and preparation method of pure traditional Chinese medicinal oil
CN106266140A (en) A kind of liniment treating acrodermatitis continua and preparation method thereof
CN102284006B (en) Externally-used paste for treating bedsore and burn-scald wounds
CN104983936A (en) Traditional Chinese medicine ointment for treating third-stage bedsore in clinical nursing
CN109646512A (en) A kind of external medicine composition for promoting chronic wound to heal
CN104306707A (en) Medicament composition for treating bedsore
CN109045204A (en) A kind of herb liquid and preparation method thereof for treating burn and scald
CN105832909A (en) Traditional Chinese medicine preparation for treating necrotic ulcer of skin
CN108653588A (en) External application traditional Chinese medicine for treating orthopedic diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20151207

Address after: 225500 No. 1 Su Zhong Road, Jiangyan District, Jiangsu, Taizhou

Patentee after: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd.

Address before: 276826 Rizhao People's Hospital, 126 Tai'an Road, Shandong, Rizhao City, China

Patentee before: Yin Defen

CP01 Change in the name or title of a patent holder

Address after: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500

Patentee after: Suzhong Pharmaceutical Group Co.,Ltd.

Address before: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500

Patentee before: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd.

CP01 Change in the name or title of a patent holder